The AI drug discovery specialist is the fifth biotechnology company to go public in February and priced the sector’s largest new stock offering in nearly three years.

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. | Generate:Biomedicines is the latest biotech to benefit from a ...

While the first couple months of the year brought a steady stream of market entries from companies in sectors such as construction tech, space tech and biotech, new offerings from SaaS companies, long ...

Despite a U.S. government shutdown that hit the “pause” button on new initial public offerings, the IPO market is expected to finish 2025 as it started, with a flurry of newly minted publicly traded ...

SpaceX is preparing a March 2026 IPO filing targeting $1.75T valuation and $50B capital raise, potentially the largest public offering ever recorded.

OpenAI secures new funding at a $730 billion valuation, positioning the ChatGPT maker for a potential record-breaking US tech ...

Data integration between IPO Prophet and PM Insights brings pre-IPO valuations and Day-1 trading intelligence together ...

York Space Systems went public Thursday -- and now trades below its offering price. This brand new space stock isn't cheap, though, costing more than 11 times annual sales. 10 stocks we like better ...

Four mainboard IPOs- Clean Max Enviro Energy Solutions, Shree Tam Twistex, PNGS Reva Diamond Jewellery and Omnitech ...

Several new-age companies that have gone public in recent months have trimmed issue sizes and settled for lower valuations as ...